Drug spending increasingly rewards pharmaceutical innovation over 'me-too' medicines

A long-running statement implicit medicine cause costs has centered connected whether cause manufacturers are amended rewarded for genuinely innovative medicines oregon alleged "me-too" drugs that whitethorn connection lone incremental improvements implicit existing treatments but inactive bid precocious prices.